(POXEL) Poxel - Performance -38.1% in 12m
Compare POXEL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-93.40%
#191 in Group
Rel. Strength
17.79%
#6569 in Universe
Total Return 12m
-38.05%
#82 in Group
Total Return 5y
-94.41%
#130 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 4.10%
90th Percentile in Group
12m Total Return: POXEL (-38.1%) vs XBI (-10.2%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-18.6% | 9.15% | 153% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-11.8% | 21% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-0.87% | 26.7% | 40.5% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-12.6% | 8.21% | 36.7% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
| LONN SW Lonza |
-3.71% | 4.01% | 31% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-1.04% | 14.6% | 7.58% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-9.08% | -23.9% | -0.25% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-4.41% | 31.6% | -2.82% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: POXEL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for POXEL
| Total Return (including Dividends) | POXEL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 94.39% | -13.99% | -6.90% |
| 3 Months | 79.72% | -13.68% | -11.64% |
| 12 Months | -38.05% | -10.17% | 6.50% |
| 5 Years | -94.41% | -19.71% | 101.06% |
| Trend Score (consistency of price movement) | POXEL | XBI | S&P 500 |
| 1 Month | 77.0% | -80.4% | -74.5% |
| 3 Months | -7.70% | -89.8% | -88.2% |
| 12 Months | -79.8% | -26.1% | 66.1% |
| 5 Years | -96.3% | -52.8% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #1 | 126% | 109% |
| 3 Month | #4 | 108% | 103% |
| 12 Month | #82 | -31.0% | -41.8% |
| 5 Years | #139 | -93.0% | -97.2% |
FAQs
Does POXEL Poxel outperforms the market?
No,
over the last 12 months POXEL made -38.05%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.17%.
Over the last 3 months POXEL made 79.72%, while XBI made -13.68%.
Over the last 3 months POXEL made 79.72%, while XBI made -13.68%.
Performance Comparison POXEL vs Indeces and Sectors
POXEL vs. Indices POXEL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -33.3% | 101% | 25.2% | -44.6% |
| US NASDAQ 100 | QQQ | -32.5% | 102% | 25.5% | -43.0% |
| US Dow Jones Industrial 30 | DIA | -31.9% | 101% | 24.9% | -43.5% |
| German DAX 40 | DAX | -36.1% | 103% | 8.11% | -56.6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -34.0% | 102% | 18.3% | -44.1% |
| Hongkong Hang Seng | HSI | -37.1% | 105% | 21.7% | -55.0% |
| India NIFTY 50 | INDA | -36.4% | 88.7% | 22.7% | -41.3% |
| Brasil Bovespa | EWZ | -37.2% | 99.0% | 23.2% | -28.4% |
POXEL vs. Sectors POXEL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -32.6% | 101% | 16.0% | -52.1% |
| Consumer Discretionary | XLY | -31.6% | 100% | 22.4% | -46.6% |
| Consumer Staples | XLP | -36.1% | 92.4% | 15.1% | -52.5% |
| Energy | XLE | -38.8% | 104% | 24.8% | -27.5% |
| Financial | XLF | -34.5% | 99.0% | 17.4% | -57.4% |
| Health Care | XLV | -33.4% | 102% | 26.5% | -37.5% |
| Industrial | XLI | -34.4% | 99.9% | 25.2% | -43.1% |
| Materials | XLB | -36.2% | 101% | 32.3% | -30.5% |
| Real Estate | XLRE | -38.3% | 97.9% | 23.6% | -55.2% |
| Technology | XLK | -32.1% | 105% | 32.1% | -35.7% |
| Utilities | XLU | -36.1% | 95.5% | 19.2% | -63.1% |
| Aerospace & Defense | XAR | -35.3% | 95.0% | 15.7% | -62.2% |
| Biotech | XBI | -39.0% | 108% | 39.7% | -27.9% |
| Homebuilder | XHB | -33.5% | 102% | 42.8% | -28.9% |
| Retail | XRT | -33.6% | 97.9% | 30.3% | -33.7% |